Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting cancer-related enzymes such as BRAF and VEGFR. Its structure supports selective binding and inhibition of abnormal protein activity in tumor cells. Also explored in the development of anti-inflammatory agents due to its sulfonamide and pyridine moieties, which contribute to cellular signaling modulation. Shows potential in optimizing drug candidates for improved metabolic stability and bioavailability.